![](https://investorshub.advfn.com/uicon/301367.png?cb=1573165358)
Friday, October 14, 2016 7:23:06 PM
It's based on the restated 10Q for 2015Q1, which was restated.
Wonder if they're going to restate their PR for Sept 14; the one that touted how much improvement their was in 2016Q1.
You know what? The PR was complete BS. Every claim was wrong. 2015Q1 was better than 2016Q1 in every aspect mentioned in PR. Even if you add back the $1.2M expense reduction in 2015Q1, the loss was still greater this current quarter.
Ball's in your court, wearers of rose-colored glasses.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM